Preparation and evaluation of transnasal microemulsion of carbamazepine

Asian Journal of Pharmaceutical Sciences

Volumn 8, Issue 1, 2013, Pages 64-70

  Acharya, Sheetal Porecha ^a   Pundarikakshudu, K ^a   Panchal, Aashish ^a   Lalwani, Anita ^b  

^a LJ Institute of Pharmacy and Research Center Ahmedabad   (India)

^b Kadi Sarva Vishwa Vidyalaya   (India)

Author keywords

Carbamazepine; Epilepsy; Intranasal; Microemulsion

Indexed keywords

EID: 84908151097     PISSN: 18180876     EISSN: 2221285X     Source Type: Journal    
DOI: 10.1016/j.ajps.2013.07.008     Document Type: Article

References (18)

1. McNamara, J.O., Drugs effective in the therapy of the epilepsies, the pharmacological basis of therapeutics. Gilman, A.G., (eds.), 1996, McGraw Hill, New York, 478–485.
2. Jongmans, J.W., Report on the antiepileptic action of tegretol. Epilepsia 5 (1964), 74–82.
3. Graves, N.M., Kriel, R.L., Jones, S.C., et al. Relative bioavailability of rectally administered carbamazepine suspension in humans. Epilepsia 26 (1985), 429–433.
4. Behl, C.R., Pimplaskar, H.K., Sileno, A.P., et al. Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Deliv Rev 29 (1998), 89–116.
5. Illum, L., Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11 (2000), 1–18.
6. Costantino, H.R., Illum, L., Brandt, G., et al. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm 337 (2007), 1–24.
7. Omar, S., Refai, H., Tahir, K., Carbamazepine mucoadhesive nanoemulgel (MNEG) as brain targeting delivery system via the olfactory mucosa. Drug Deliv 19:1 (2012), 58–67.
8. Eccleston, G.M., MEs. Swarbrick, S., Boylan, J.C., (eds.) Encyclopedia of pharmaceutical technology, 9, 1992, Marcel Dekker, New York, 375–421.
9. Gao, Z.G., Choi, H.G., Shin, H.J., et al. Physicochemical characterization and evaluation of a ME system for oral delivery of cyclosporin A. Int J Pharm 161 (1998), 75–86.
10. Qizhi, Z., Xinguo, J., Wenming, J., et al. Preparation of nimodipine-loaded ME for intranasal delivery and evaluation on the targeting efficiency to the brain. Int J Pharm 275 (2004), 85–96.
11. Srinivas, C., Sagar, V.S., Enhancing the bioavailability of simvastatin using microemulsion drug delivery system. Asian J Pharm Clin Re 15:4 (2012), 134–139.
12. Zhu, Weiwei, Yu, Aihua, Wang, Weihong, et al. Formulation design of ME for dermal delivery of penciclovir. Int J Pharm 360 (2008), 184–190.
13. Gannu, R., Reddy, C., Vishnu, P.V., et al. Enhanced bioavailability of lacidipine via ME based transdermal gels: formulation optimization, ex vivo and in vivo characterization. Int J Pharm 388 (2010), 231–241.
14. Porecha, S., Shah, T., Jogani, V., et al. Microemulsion based intranasal delivery system for treatment of insomnia. Drug Deliv 16:3 (2009), 128–134.
15. Woodbury, J.W., Woodbury, D.M., Vagal stimulation reduces the seventy of maximal electroshock seizures in intact rats: use of a cuff electrode for stimulating and recording. Pacing Clin Electrophysiol 14 (1991), 94–107.
16. Hongxia, L., Matthias, G., Shengjie, B., et al. Enhancing effect of surfactants on fexofenadine·HCl transport across the human nasal epithelial cell monolayer. Int J Pharm 330 (2007), 23–31.
17. Barot, B., Parejiya, P., Patel, H., et al. Microemulsion-based gel of terbinafine for the treatment of onychomycosis:optimization of formulation using D-optimal design. AAPS Pharm Sci Tech 13:1 (2012), 184–192.
18. Lu, H.T., Chen, R.N., Sheu, M.T., et al. Rapid-onset sildenafil nasal spray carried by ME systems: in vitro evaluation and in vivo pharmacokinetic studies in rabbits. Xenobiotica 41:7 (2011), 567–577.